Employer record · Whippany, NJ · FY2025–FY2025

Axela Biosciences Inc.

    Certified LCAs
    3
    FY2024–FY2026
    USCIS approvals
    1
    1 new employment
    Denial rate
    50.0%
    FY2024–FY2026
    Median wage offered
    $75k
    certified LCAs

    Jobs not indexed yet

    Does Axela Biosciences Inc. sponsor H-1B visas?

    Yes — by its record, Axela Biosciences Inc. is a small-scale H-1B sponsor: it filed 3 certified Labor Condition Applications (LCAs) in FY2024–FY2026 and received 1 USCIS H-1B petition approvals (1 for new employment). Its latest certified LCA in our data was decided Aug 21, 2025. Past filings are history, not a promise: they do not mean the employer will sponsor you or a given role.

    Updated · DOL OFLC LCA disclosure + USCIS H-1B Employer Data Hub

    Filings by fiscal year

    Certified LCAs per U.S. government fiscal year (Oct–Sep); the slim bar is USCIS petition approvals (new + continuing), the bottom row their approval rate.

    Axela Biosciences Inc. certified LCAs by fiscal year
    Fiscal yearcertified LCAsUSCIS approvalsApproval rate
    FY2530–
    FY260150%

    Occupations sponsored

    Occupation (SOC)LCAsMedian wage
    Management Analysts 13-11111$82k
    Molecular and Cellular Biologists 19-10291$75k
    Biological Technicians 19-40211$55k

    Most-filed job titles

    1. Associate Scientist, Biology1$75k
    2. Biotech Business Management Analyst1$82k
    3. Senior Research Associate1$55k

    LCAs per title and median wage offered.

    Where the jobs were

    1. New Jersey2 LCAs
    2. New York1 LCAs

    We haven't indexed Axela Biosciences' jobs yet

    We read jobs straight from employers' own career sites and haven't added Axela Biosciences' yet. Its H-1B record on this page comes from public DOL and USCIS data and is not affected.

    Also filed as

    • Axela Biosciences Inc. (LCA)
    • Axela Biosciences, Inc. (LCA)
    • AXELA BIOSCIENCES INC (USCIS)

    Axela Biosciences Inc. H-1B: questions people ask

    Does Axela Biosciences Inc. sponsor H-1B visas?

    Yes — by its record, Axela Biosciences Inc. is a small-scale H-1B sponsor: it filed 3 certified Labor Condition Applications (LCAs) in FY2024–FY2026 and received 1 USCIS H-1B petition approvals (1 for new employment). Its latest certified LCA in our data was decided Aug 21, 2025. Past filings are history, not a promise: they do not mean the employer will sponsor you or a given role.

    Is Axela Biosciences Inc. still sponsoring H-1B in 2026?

    Axela Biosciences Inc. had 0 certified LCAs in FY2026 (Oct 2025–Sep 2026), fewer than the 3 in FY2025. The latest one in our data was decided Aug 21, 2025. An LCA is filed before a petition, so it shows recent intent to hire on H-1B, not a hire.

    How many H-1B petitions does Axela Biosciences Inc. get approved?

    USCIS recorded 1 approvals (1 for new employment, the rest continuing employment such as extensions and transfers) and 1 denials for Axela Biosciences Inc. in FY2024–FY2026 — a denial rate of 50.0%. Source: USCIS H-1B Employer Data Hub (first decisions).

    What is the H-1B salary at Axela Biosciences Inc.?

    The median wage offered on Axela Biosciences Inc.'s certified LCAs in FY2024–FY2026 was $75k a year. By job title: Associate Scientist, Biology $75k (1 LCAs), Biotech Business Management Analyst $82k (1 LCAs) and Senior Research Associate $55k (1 LCAs). LCA wages are the pay the employer attested to; actual pay can be higher.

    Which jobs does Axela Biosciences Inc. sponsor for H-1B?

    Its certified LCAs in FY2024–FY2026 were mostly for Management Analysts (1), Molecular and Cellular Biologists (1) and Biological Technicians (1).

    Where are Axela Biosciences Inc.'s H-1B jobs?

    By worksite on its certified LCAs (FY2024–FY2026): New Jersey (2) and New York (1).

    Is Axela Biosciences Inc. an H-1B dependent employer?

    No — its recent LCAs do not declare it H-1B dependent.

    Does Axela Biosciences Inc. have open jobs?

    We read jobs straight from employers' own career sites and haven't added Axela Biosciences' yet.